About 1 result found for searched term "Olendalizumab" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24989 | Olendalizumab | Complement System |
| ALXN1007 | ||
| Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
